01 4Vafseo
Main Therapeutic Indication : Nephrology
Currency : USD
2021 Revenue in Millions : 7
2020 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Nephrology
Currency : USD
2022 Revenue in Millions : 15
2021 Revenue in Millions : 8
Growth (%) : 79
Main Therapeutic Indication : Nephrology
Currency : USD
2023 Revenue in Millions : 15
2022 Revenue in Millions : 15
Growth (%) : 15
Main Therapeutic Indication : Nephrology
Currency : USD
2024 Revenue in Millions : 14
2023 Revenue in Millions : 17
Growth (%) : -17
